3.54
+0.02(+0.57%)
Currency In USD
Previous Close | 3.52 |
Open | 3.51 |
Day High | 3.68 |
Day Low | 3.48 |
52-Week High | 4.5 |
52-Week Low | 0.13 |
Volume | 1.96M |
Average Volume | 1.89M |
Market Cap | 330.97M |
PE | -5.28 |
EPS | -0.67 |
Moving Average 50 Days | 3.57 |
Moving Average 200 Days | 2.09 |
Change | 0.02 |
If you invested $1000 in The Oncology Institute, Inc. (TOI) since IPO date, it would be worth $364.95 as of September 29, 2025 at a share price of $3.54. Whereas If you bought $1000 worth of The Oncology Institute, Inc. (TOI) shares 3 years ago, it would be worth $753.19 as of September 29, 2025 at a share price of $3.54.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
The Oncology Institute Achieves $1.1 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 2 through its California Professional Corporation
GlobeNewswire Inc.
Sep 22, 2025 12:00 PM GMT
Practice earns maximum quality points on avoidable ED visits and admissions, saving more than $3,500 per episodeCERRITOS, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based
The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos
GlobeNewswire Inc.
Sep 02, 2025 8:05 PM GMT
CERRITOS, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, today announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florid
The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida
GlobeNewswire Inc.
Aug 18, 2025 12:00 PM GMT
CERRITOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a national leader in value-based oncology care, is pleased to announce a strategic partnership with Doctors HealthCare Plans, a Medicar